Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. Herrschaft H, et al. Among authors: schlaefke s. J Psychiatr Res. 2012 Jun;46(6):716-23. doi: 10.1016/j.jpsychires.2012.03.003. Epub 2012 Mar 27. J Psychiatr Res. 2012. PMID: 22459264 Clinical Trial.
Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
von Gunten A, Schlaefke S, Überla K. von Gunten A, et al. Among authors: schlaefke s. World J Biol Psychiatry. 2016 Dec;17(8):622-633. doi: 10.3109/15622975.2015.1066513. Epub 2015 Jul 30. World J Biol Psychiatry. 2016. PMID: 26223956 Review.
Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.
Gauthier S, Schlaefke S. Gauthier S, et al. Among authors: schlaefke s. Clin Interv Aging. 2014 Nov 28;9:2065-77. doi: 10.2147/CIA.S72728. eCollection 2014. Clin Interv Aging. 2014. PMID: 25506211 Free PMC article. Review.
Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting.
Rainer M, Mucke H, Schlaefke S. Rainer M, et al. Among authors: schlaefke s. Wien Klin Wochenschr. 2013 Jan;125(1-2):8-15. doi: 10.1007/s00508-012-0307-x. Epub 2013 Jan 5. Wien Klin Wochenschr. 2013. PMID: 23292640
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.
Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R; GINDON Study Group. Yancheva S, et al. Among authors: schlaefke s. Aging Ment Health. 2009 Mar;13(2):183-90. doi: 10.1080/13607860902749057. Aging Ment Health. 2009. PMID: 19347685 Clinical Trial.
Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder.
Uehleke B, Schaper S, Dienel A, Schlaefke S, Stange R. Uehleke B, et al. Among authors: schlaefke s. Phytomedicine. 2012 Jun 15;19(8-9):665-71. doi: 10.1016/j.phymed.2012.02.020. Epub 2012 Apr 3. Phytomedicine. 2012. PMID: 22475718 Clinical Trial.
Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control study.
Golka K, Bandel T, Schlaefke S, Reich SE, Reckwitz T, Urfer W, Bremicker KD, Neugebauer W, Soekeland J, Bolt HM. Golka K, et al. Among authors: schlaefke s. Int J Occup Environ Health. 1998 Apr-Jun;4(2):79-84. doi: 10.1179/oeh.1998.4.2.79. Int J Occup Environ Health. 1998. PMID: 10026468
Feedback